Last reviewed · How we verify

Ketorolac Injection 60 mg

William Beaumont Army Medical Center · FDA-approved active Small molecule Quality 5/100

Ketorolac Injection 60 mg is a Small molecule drug developed by William Beaumont Army Medical Center. It is currently FDA-approved. Also known as: Toradol, ketorolac tromethamine, ketorolac.

At a glance

Generic nameKetorolac Injection 60 mg
Also known asToradol, ketorolac tromethamine, ketorolac
SponsorWilliam Beaumont Army Medical Center
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Ketorolac Injection 60 mg

What is Ketorolac Injection 60 mg?

Ketorolac Injection 60 mg is a Small molecule drug developed by William Beaumont Army Medical Center.

Who makes Ketorolac Injection 60 mg?

Ketorolac Injection 60 mg is developed and marketed by William Beaumont Army Medical Center (see full William Beaumont Army Medical Center pipeline at /company/william-beaumont-army-medical-center).

Is Ketorolac Injection 60 mg also known as anything else?

Ketorolac Injection 60 mg is also known as Toradol, ketorolac tromethamine, ketorolac.

What development phase is Ketorolac Injection 60 mg in?

Ketorolac Injection 60 mg is FDA-approved (marketed).

Related